Skip to main content

Table 1 Patient characteristics

From: Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy

Docetaxel dose

20 mg/m2

100 mg/m2

Number of patients

15

19

Sex

  

   Male

11

7

   Female

4

12

Age, years

  

   Median

69

63

   Range

47–81

45–75

Histological type

  

   Adenocarcinoma

3

12

   Squamous cell

9

4

   Large cell

1

2

   Undifferentiated

2

1

Performance status

  

   ECOG 0

6

5

   ECOG 1

7

10

   ECOG 2

2

4

Stage

  

   IIIA

3

 

   IIIB

12

4

   IV

 

15